{"url_path":"/sec/bkyi/10-k/2026/item-5","section_key":"item-5","section_title":"Item 5 ** **MARKET FOR REGISTRANT**’**S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-020446-index.html","accession_number":"0001437749-26-020446","cik":"0001019034","ticker":"BKYI","issuer_name":"BIO KEY INTERNATIONAL INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-020446-index.html","primary_entity_key":"0001019034","primary_entity_name":"BIO KEY INTERNATIONAL INC"},"word_count":228,"has_tables":true,"body_markdown":"**ITEM 5.** **MARKET FOR REGISTRANT**’**S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**\n\n \n\nOur common stock currently trades on the OTC Markets under the symbol “BKYI”.\n\n \n\n**Holders**\n\n \n\nAs of June 10, 2026, the number of stockholders of record of our common stock was 171.\n\n \n\n**Dividends**\n\n \n\nWe have not paid any cash dividends on our common stock to-date and have no intention of paying any cash dividends on our common stock in the foreseeable future. The declaration and payment of dividends on our common stock is also subject to the discretion of our Board of Directors and certain limitations imposed under the Delaware General Corporation Law. The timing, amount, and form of dividends, if any, will depend on, among other things, our results of operations, financial condition, cash requirements and other factors deemed relevant by our Board of Directors.\n\n \n\n**Securities Authorized for Issuance under Equity Compensation Plans**\n\n \n\nFor information on securities authorized for issuance under the Company’s equity compensation plans, see “Item 12 - Security Ownership of Certain Beneficial Owners and Related Stockholder Matters.”\n\n \n\n**Unregistered Sales of Equity Securities**\n\n \n\nThere were no unregistered sales of the Company’s equity securities during 2025 that were not previously disclosed in a Quarterly Report on Form 10-Q or in a Current Report on Form 8-K.\n\n \n\n**Issuer Purchases of Equity Securities**\n\n \n\nNone.\n\n \n\n**ITEM** **6. RESERVED**\n\n \n\nNot Applicable.\n\n \n\n19\n\n[Table of Contents](#toc)"}